March 6, 2008 - Bar Harbor BioTechnology Inc. announced the launch of its new line of human StellARray™ products for gene expression research today. This initial offering of 43 different biological pathways for scientists to select from includes many major human diseases. Configured to perform gene expression or gene copy number experiments these new Real-Time PCR arrays are the first of their kind in the field of gene expression research.
"Scientists researching human diseases like obesity, osteoporosis, and Alzheimer's disease have a new method for detecting subtle changes in how a group of genes are expressed. That could lead to a breakthrough in their research," says Robert Phelps, President of Bar Harbor BioTechnology Inc... Bar Harbor BioTechnology's Press Release -
Blog Archive
-
▼
2008
(79)
-
▼
March
(11)
- ExonHit, EHT 0202 Counters Scopolamine's Detriment...
- Cryo-Cell International : Umbilical Cord Blood Cel...
- Evotec's EVT 101 : to Penetrate the Brain in Man a...
- Eisai, Application for Aricept Oral Jelly Formulat...
- Neurobiological Technologies and Buck Institute, t...
- Bar Harbor BioTechnology : New Line of StellARrays
- Power3 Medical , Three Hundred Patient Clinical Va...
- Pharmatrophix Alzheimer's Drug Discovery Foundatio...
- Hunter-Fleming and Newron, continuation of phase I...
- Debiopharm's Debio 9902 SR in Alzheimer’s disease,...
- Power3 Medical, Patent Application for Forty-Seven...
-
▼
March
(11)